BMC Medical Co., Ltd. (SHE:301367)
China flag China · Delayed Price · Currency is CNY
40.26
-0.83 (-2.02%)
At close: Nov 13, 2026

BMC Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,4371,158842.241,1191,413661.08
Other Revenue
1.361.361.243.012.621.42
1,4381,159843.481,1221,415662.5
Revenue Growth
37.05%37.46%-24.85%-20.70%113.64%18.20%
Cost of Revenue
667.98555.87449.31619.28828.15377.5
Gross Profit
770.51603.55394.17503.14587.22285
Selling, General & Admin
369.76256.16172.58142.35131.6895.52
Research & Development
149.59139.12124.62116.9872.8648.28
Other Operating Expenses
-41.05-17.43-2.76-23.5-19.3-9.51
Operating Expenses
479.12380.25297.2238.62189.01134.53
Operating Income
291.39223.3196.98264.51398.2150.47
Interest Expense
-2.31-4.97-2.85-1.36-0.46-0.2
Interest & Investment Income
56.3657.6162.3663.3620.0911.56
Currency Exchange Gain (Loss)
-10.97-10.974.51-0.411.98-3.67
Other Non Operating Income (Expenses)
-34.21-1.11-0.850.2-0.26-0.53
EBT Excluding Unusual Items
300.26263.87160.14326.31429.55157.64
Gain (Loss) on Sale of Investments
-34.3-7.8210.44---
Gain (Loss) on Sale of Assets
0.20.260.190.480.02-
Asset Writedown
4.85-0.83-3.06-0.02--0.01
Other Unusual Items
5.955.898.427.275.526.24
Pretax Income
276.96261.36176.14334.03435.09163.86
Income Tax Expense
38.5930.117.5434.254.0618.18
Earnings From Continuing Operations
238.37231.26158.6299.83381.03145.68
Minority Interest in Earnings
-6.72-5.6-3.22-2.49-0.74-
Net Income
231.65225.66155.38297.34380.3145.68
Net Income to Common
231.65225.66155.38297.34380.3145.68
Net Income Growth
10.17%45.23%-47.74%-21.81%161.05%-36.07%
Shares Outstanding (Basic)
1241241251259994
Shares Outstanding (Diluted)
1241241251259994
Shares Change
0.04%-0.51%-0.29%26.33%5.67%-0.16%
EPS (Basic)
1.861.811.242.373.831.55
EPS (Diluted)
1.861.811.242.373.831.55
EPS Growth
10.12%45.97%-47.59%-38.11%147.04%-35.96%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
80.197.94138.16126.98351.4694.38
Free Cash Flow Per Share
0.650.791.101.013.541.00
Dividend Per Share
0.4710.4710.2860.5101.020-
Dividend Growth
65.00%65.00%-44.00%-50.00%233.35%-
Gross Margin
53.56%52.06%46.73%44.83%41.49%43.02%
Operating Margin
20.26%19.26%11.50%23.57%28.13%22.71%
Profit Margin
16.10%19.46%18.42%26.49%26.87%21.99%
Free Cash Flow Margin
5.57%8.45%16.38%11.31%24.83%14.24%
EBITDA
301.88234.68109.53274.46403.85155.09
EBITDA Margin
20.99%20.24%12.98%24.45%28.53%23.41%
D&A For EBITDA
10.4911.3812.559.955.654.62
EBIT
291.39223.3196.98264.51398.2150.47
EBIT Margin
20.26%19.26%11.50%23.57%28.13%22.71%
Effective Tax Rate
13.93%11.52%9.96%10.24%12.42%11.09%
Revenue as Reported
1,4381,159843.481,1221,415662.5
Advertising Expenses
---39.676.744.26